With extensive industry knowledge and expertise, Viva Ventures has invested in over 20 biotech startups across various therapeutic areas. The fund has achieved successful exits through M&A and IPOs, and differentiates itself from traditional biotech VCs by focusing on discovery-stage investments with low risk and high returns. The fund typically invests in rounds with more than 10 participants and has meaningful sponsors such as Quark Venture, Polaris Partners, and NanoDimension. Viva Ventures primarily invests in startups that are 4-5 years old and seeks deals in the range of $50-100 million. Founded in 2008, the firm is based in Hong Kong and prefers to invest in the biotechnology sector.